Tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine
C55H56F6N14O2 — CID 163513906
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine
Tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine (PubChem CID 163513906) has the molecular formula C55H56F6N14O2 and a molecular weight of 1059.14 g/mol. Its IUPAC name is tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine.
Molecular Properties
| Compound Name | Tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine |
|---|---|
| PubChem CID | 163513906 |
| Molecular Formula | C55H56F6N14O2 |
| Molecular Weight | 1059.14 g/mol |
| Exact Mass | 1058.46 |
| IUPAC Name | tert-butyl 4-[4-[6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrido[3,2-d]pyrimidin-4-yl]pyrazol-1-yl]piperidine-1-carboxylate;6-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]-4-(1-piperidin-4-ylpyrazol-4-yl)pyrido[3,2-d]pyrimidine |
| SMILES | CC(C)(C)OC(=O)N1CCC(n2cc(-c3ncnc4ccc(N5C[C@@H](F)C[C@@H]5c5cc(F)ccc5F)nc34)cn2)CC1.Fc1ccc(F)c([C@H]2C[C@H](F)CN2c2ccc3ncnc(-c4cnn(C5CCNCC5)c4)c3n2)c1 |
| InChI | InChI=1S/C30H32F3N7O2.C25H24F3N7/c1-30(2,3)42-29(41)38-10-8-21(9-11-38)40-15-18(14-36-40)27-28-24(34-17-35-27)6-7-26(37-28)39-16-20(32)13-25(39)22-12-19(31)4-5-23(22)33;26-16-1-2-20(28)19(9-16)22-10-17(27)13-34(22)23-4-3-21-25(33-23)24(31-14-30-21)15-11-32-35(12-15)18-5-7-29-8-6-18/h4-7,12,14-15,17,20-21,25H,8-11,13,16H2,1-3H3;1-4,9,11-12,14,17-18,22,29H,5-8,10,13H2/t20-,25+;17-,22+/m00/s1 |
| InChIKey | DFBDKNNDGKEZHF-KXCPMKGLSA-N |
| XLogP | 10.41 |
| TPSA | 161.03 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 77 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1059.14 |
| LogP ≤ 5 | 10.41 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163513906 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.